Abstract:Abstract Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated malignancy most common in East Asia and Africa. Previous studies have reported that genetic susceptibility is associated with NPC. Jab1/CSN5 promotes cell growth and proliferation. Recent studies have shown that Jab1/CSN5 is aberrantly expressed, is correlated with low expression of p27, and is associated with advanced tumor stage and poor prognosis in several human cancers. In this study, we examined the functional role and correlation between Jab1/CSN5 and p27 protein expression in NPC tissue samples and cell lines, the association of their expression with clinical outcome and the antitumor effects of cisplatin in NPC cells. Immunohistochemical analysis showed that Jab1/CSN5 aberrant expression was inversely associated with p27 expression in NPC tissue samples, and Jab1/CSN5 overexpression was correlated with poor survival (p<0.01). Further analysis showed that Jab1/CSN5 mediated p27 degradation in a proteasome-dependent manner, and Jab1/CSN5 directly interacted with p27 in NPC cells. In addition, inactivation of Jab1/CSN5 by small interfering RNAs resulted in a remarkable increase in p27 levels and in the inhibition of cell proliferation, thereby indicating that Jab1/CSN5 controls the stability of p27 by targeting it for degradation in NPC. Moreover, suppression of Jab1/CSN5 enhanced the antitumor effects of cisplatin in NPC cells. To our knowledge, these findings are the first to suggest that Jab1/CSN5 overexpression is involved in NPC pathogenesis via Jab1-mediated p27 degradation, thus explaining the low p27 levels seen in NPC. Therefore, Jab1/CSN5 could be a diagnostic marker and a novel therapeutic target in patients with NPC. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1855. doi:1538-7445.AM2012-1855

The Pivotal Oncogenic Role of Jab1/CSN5 and Its Therapeutic Implications in Human Cancer

Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.

Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

Jab1/Cops5: a Promising Target for Cancer Diagnosis and Therapy

Pan-cancer Analyses of Jab1/COPS5 Reveal Oncogenic Role and Clinical Outcome in Human Cancer

Prognostic Role Of C-Jun Activation Domain-Binding Protein-1 In Cancer: A Systematic Review And Meta-Analysis

Prognostic Role of C‐jun Activation Domain‐binding Protein‐1 in Cancer: A Systematic Review and Meta‐analysis

Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

Role of the COP1 protein in cancer development and therapy

CSN6: a promising target for cancer prevention and therapy.

Abstract 1855: Jab1/CSN5 a Negative Regulator of P27 Plays a Role in the Pathogenesis and Cisplatin Sensitivity of Nasopharyngeal Carcinoma

Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51

The Biological Roles of ZKSCAN3 (ZNF306) in the Hallmarks of Cancer: from Mechanisms to Therapeutics

Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

Data from Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma

The Roles of ZEB1 in Tumorigenic Progression and Epigenetic Modifications

The Janus Face of P53-Targeting Ubiquitin Ligases

DNAJC5 Promotes Hepatocellular Carcinoma Cells Proliferation Though Regulating SKP2 Mediated P27 Degradation

A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1.

Down-Regulation of the Cyclin-Dependent Kinase Inhibitor P57 is Mediated by Jab1/Csn5 in Hepatocarcinogenesis